Comparable stake leader
Timothy P. Lynch
SEC ownership of Evolus, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001570562.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- EOLS on Nasdaq
- Parsed ownership sources
- 13D/G, 13F, and 3/4/5
- Largest SEC-reported holder
- Timothy P. Lynch
- Latest 13D/G holder
- Timothy P. Lynch
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0001570562
- Issuer location
- Newport Beach, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Evolus, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Timothy P. Lynch
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: Timothy P. Lynch
Showing 1-8 of 50 holder rows.
Quick read
Timothy P. Lynch leads the comparable SEC ownership view at 9.9%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Timothy P. Lynch's linked filing trail.
Comparable ownership
Top 5
Timothy P. Lynch
9.9%
Nantahala Capital Management, LLC
8.8%
BlackRock, Inc.
6.9%
PERCEPTIVE ADVISORS LLC
3.8%
Medytox Inc.
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Timothy P. Lynch |
13D/G
|
9.9%
|
$36,305,352
6,425,726 shares
|
+$7,299,518 | 31 Dec 2025 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
8.8%
|
$35,162,902
5,726,857 shares
|
+$12,129,656 | 30 Sep 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
6.9%
|
$50,851,038
4,364,896 shares
|
$0 | 31 Dec 2024 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
3.8%
|
$23,461,512
2,474,843 shares
|
-$15,682,755 | 30 Jun 2025 |
| Medytox Inc. |
3/4/5
13D/G
Former 10% Owner
|
3.4%
from 13D/G
|
$25,359,945
3,381,326 shares
|
— | 16 Oct 2023 |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
1.9%
|
$7,038,160
1,245,692 shares
|
-$21,197,145 | 31 Dec 2025 |
| BRAIDWELL LP |
13F
Company
|
4.8%
|
$12,762,409
3,105,209 shares
|
— | 31 Mar 2026 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
4.1%
|
$10,812,033
2,630,665 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,821,147.
Buys
$393,486
Insiders: 2
Sells
$2,214,633
Insiders: 3
Net
-$1,821,147
Shares: -259,931
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 50,000
Shares: 309,931
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 163,504 | $0 | $796,936 | -$796,936 |
| 3-6 | 0 | 12,800 | $0 | $91,529 | -$91,529 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 50,000 | 133,627 | $393,486 | $1,326,167 | -$932,681 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to Evolus, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Alphaeon 1 LLC
Net 12M change
-$1,821,146
Latest report
20 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Alphaeon 1 LLC | 10%+ Owner | $35,404,916 | Filing P/S | 17 Feb 2023 | ||
| Medytox Inc. | Former 10% Owner | $25,359,945 | Filing P/S | 16 Oct 2023 | ||
| Simone Blank | Director | $6,075,914 | Mixed | 07 Mar 2025 | ||
| David Moatazedi | President & Chief Executive Officer, Director | $4,942,917 | -$1,994,048 | -29% | Mixed | 20 Mar 2026 |
| Rui Avelar | Officer | $2,288,274 | -$177,612 | -7.2% | Mixed | 20 Mar 2026 |
| Sandra Beaver | Chief Financial Officer | $2,061,242 | Mixed | 13 May 2025 | ||
| Vikram Malik | Director | $1,611,967 | Mixed | 17 Feb 2026 | ||
| Lauren P. Silvernail | Chief Financial Officer and Executive Vice President, Corporate Development | $1,377,288 | Mixed | 17 May 2022 | ||
| Crystal Muilenburg | Chief Marketing Officer | $1,306,045 | Mixed | 08 Mar 2022 | ||
| Tatjana Mitchell | Chief Financial Officer | $1,134,981 | Mixed | 17 Feb 2026 | ||
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | $869,027 | -$42,972 | -4.7% | Mixed | 22 Aug 2025 |
| Robert Hayman | Director | $856,795 | Mixed | 07 Feb 2024 | ||
| Brady Stewart | Director | $673,623 | +$204,486 | +44% | Mixed | 17 Feb 2026 |
| Chairman Emeritus Peter C. Farrell | Director | $517,309 | Mixed | 27 Jan 2023 | ||
| Albert G. White III | Director | $481,603 | +$189,000 | +65% | Mixed | 17 Feb 2026 |
| David N. Gill | Director | $436,172 | Mixed | 17 Feb 2026 | ||
| Karah Herdman Parschauer | Director | $390,264 | Mixed | 17 Feb 2026 |
Recent insider transactions for Evolus, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Rui Avelar | EOLS | Common Stock | Sale | -0.72% | $14,815 | $4.75 | -3,119 | 427,423 | 20 Mar 2026 | Direct |
| David Moatazedi | EOLS | Common Stock | Sale | -2.21% | $64,929 | $4.75 | -13,669 | 604,700 | 20 Mar 2026 | Direct |
| David Moatazedi | EOLS | Common Stock | Sale | -15.9% | $570,562 | $4.89 | -116,720 | 618,369 | 17 Mar 2026 | Direct |
| Rui Avelar | EOLS | Common Stock | Sale | -6.51% | $146,629 | $4.89 | -29,996 | 430,542 | 17 Mar 2026 | Direct |
| David Moatazedi | EOLS | Common Stock | Options Exercise | 10.1% | 67,489 | 735,089 | 16 Mar 2026 | Direct | ||
| David Moatazedi | EOLS | Performance Restricted Stock Units | Options Exercise | -50% | -67,489 | 67,488 | 16 Mar 2026 | Direct | ||
| Rui Avelar | EOLS | Common Stock | Options Exercise | 1.95% | 8,804 | 460,538 | 16 Mar 2026 | Direct | ||
| Rui Avelar | EOLS | Performance Restricted Stock Units | Options Exercise | -50% | -8,804 | 8,802 | 16 Mar 2026 | Direct | ||
| Karah Herdman Parschauer | EOLS | Common Stock | Award | 141.6% | 45,559 | 77,742 | 17 Feb 2026 | Direct | ||
| Brady Stewart | EOLS | Common Stock | Award | 51.4% | 45,559 | 134,188 | 17 Feb 2026 | Direct | ||
| Tatjana Mitchell | EOLS | Common Stock | Award | 116.1% | 121,489 | 226,092 | 17 Feb 2026 | Direct | ||
| Tatjana Mitchell | EOLS | Stock Option (Right to Buy) | Award | 177,471 | 177,471 | 17 Feb 2026 | Direct | |||
| Tatjana Mitchell | EOLS | Performance Restricted Stock Units | Award | 121,489 | 121,489 | 17 Feb 2026 | Direct | |||
| Albert G. White III | EOLS | Common Stock | Award | 90.4% | 45,559 | 95,937 | 17 Feb 2026 | Direct | ||
| David Moatazedi | EOLS | Common Stock | Award | 88.4% | 313,212 | 667,600 | 17 Feb 2026 | Direct | ||
| David Moatazedi | EOLS | Stock Option (Right to Buy) | Award | 457,541 | 457,541 | 17 Feb 2026 | Direct | |||
| David Moatazedi | EOLS | Performance Restricted Stock Units | Award | 626,424 | 626,424 | 17 Feb 2026 | Direct | |||
| Vikram Malik | EOLS | Common Stock | Award | 16.5% | 45,559 | 321,109 | 17 Feb 2026 | Direct | ||
| Rui Avelar | EOLS | Common Stock | Award | 26.6% | 94,913 | 451,734 | 17 Feb 2026 | Direct | ||
| Rui Avelar | EOLS | Stock Option (Right to Buy) | Award | 138,649 | 138,649 | 17 Feb 2026 | Direct | |||
| Rui Avelar | EOLS | Performance Restricted Stock Units | Award | 94,913 | 94,913 | 17 Feb 2026 | Direct | |||
| David N. Gill | EOLS | Common Stock | Award | 110.2% | 45,559 | 86,887 | 17 Feb 2026 | Direct | ||
| David Moatazedi | EOLS | Common Stock | Sale | -2.89% | $75,361 | $7.15 | -10,539 | 354,388 | 22 Dec 2025 | Direct |
| Rui Avelar | EOLS | Common Stock | Sale | -0.63% | $16,168 | $7.15 | -2,261 | 356,821 | 22 Dec 2025 | Direct |
| Tatjana Mitchell | EOLS | Common Stock | Award | 104,603 | 104,603 | 08 Sep 2025 | Direct | |||
| Tatjana Mitchell | EOLS | Stock Option (Right to Buy) | Award | 143,403 | 143,403 | 08 Sep 2025 | Direct | |||
| Tomoko Yamagishi-Dressler | EOLS | Common Stock | Sale | -5.98% | $42,972 | $7.51 | -5,722 | 89,949 | 22 Aug 2025 | Direct |
| Brady Stewart | EOLS | Common Stock | Purchase | 51.2% | $204,486 | $6.82 | 30,000 | 88,629 | 15 Aug 2025 | Direct |
| David Moatazedi | EOLS | Common Stock | Sale | -4.35% | $164,054 | $9.89 | -16,582 | 364,927 | 16 Jun 2025 | Direct |
| David Moatazedi | EOLS | Common Stock | Sale | -22.6% | $1,119,141 | $10.05 | -111,323 | 381,509 | 13 Jun 2025 | Direct |
| Albert G. White III | EOLS | Common Stock | Purchase | 65.8% | $189,000 | $9.45 | 20,000 | 50,378 | 09 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.